Korean traditional Chungkookjang improves body composition, lipid profiles and atherogenic indices in overweight/obese subjects: a double-blind, randomized, crossover, placebo-controlled clinical trial

被引:39
|
作者
Byun, M-S [1 ,2 ]
Yu, O-K [1 ]
Cha, Y-S [1 ,2 ]
Park, T-S [1 ,3 ]
机构
[1] Chonbuk Natl Univ, Dept Obes Res Ctr, Jeonju, South Korea
[2] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, 664-14 Duckjin Dong, Jeonju 561756, Jeonbuk, South Korea
[3] Chonbuk Natl Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Jeonju, South Korea
关键词
SOY-PROTEIN; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-B; OBESE SUBJECTS; RISK MARKERS; WEIGHT-LOSS; CHOLESTEROL; ATHEROSCLEROSIS; SUPPLEMENTATION; DYSLIPIDEMIA;
D O I
10.1038/ejcn.2016.77
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BACKGROUND/OBJECTIVES: Chungkookjang is a Korean representative fermented soybean food. In this study, we investigated the effect of Korean traditional Chungkookjang compared with placebo on body composition, dyslipidemia and risk factors for atherosclerosis in overweight/obese subjects. SUBJECTS/METHODS: This double-blind, randomized, controlled crossover trial was conducted on 120 overweight/obese subjects, aged 19-29 years. Subjects were randomly divided into a Chungkookjang (n = 60) or a placebo (n = 60) group. After 12 weeks, the groups were crossed over for an additional 12 weeks. During the intervention period, subjects were asked to maintain their usual diet and activity and not to take any functional foods or dietary supplements. The anthropometric measures, lipid profiles and atherogenic indices were determined at baseline and at the end of each 12-week period. RESULTS: The anthropometry measurements, percentage body fat, lean body mass, waist circumference and waist-to-hip ratio of women in the Chungkookjang group were significantly improved compared with the placebo group. Lipid profiles and high-sensitivity C-reactive protein of women in Chungkookjang were significantly improved. The atherogenic indices of apolipoprotein B/apolipoprotein A1 decreased in both the placebo and the Chungkookjang group, and it also decreased below 0.55 for all the men and women in the Chungkookjang group. CONCLUSIONS: In conclusion, these results suggest that supplementation with Chungkookjang may improve body composition and risk factors for cardiovascular disease in overweight and obese adults.
引用
收藏
页码:1116 / 1122
页数:7
相关论文
共 50 条
  • [21] Nutraceutical Improves Glycemic Control, Insulin Sensitivity, and Oxidative Stress in Hyperglycemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Bumrungpert, Akkarach
    Pavadhgul, Patcharanee
    Chongsuwat, Rewadee
    Komindr, Surat
    NATURAL PRODUCT COMMUNICATIONS, 2020, 15 (04)
  • [22] A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes
    Park, Soo-Hyun
    Bae, Ui-Jin
    Choi, Eun-Kyung
    Jung, Su-Jin
    Lee, Sung-Hyen
    Yang, Jae-Heon
    Kim, You-Suk
    Jeong, Do-Youn
    Kim, Hyun-Ju
    Park, Byung-Hyun
    Chae, Soo-Wan
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 20 (01) : 211
  • [23] Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial
    Karamali, M.
    Dadkhah, F.
    Sadrkhanlou, M.
    Jamilian, M.
    Ahmadi, S.
    Tajabadi-Ebrahimi, M.
    Jafari, P.
    Asemi, Z.
    DIABETES & METABOLISM, 2016, 42 (04) : 234 - 241
  • [24] Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence
    Manzardo, Ann M.
    He, Jianghua
    Poje, Albert
    Penick, Elizabeth C.
    Campbell, Jan
    Butler, Merlin G.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (02) : 562 - 570
  • [25] Bupropion for Overweight Women With Binge-Eating Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    White, Marney A.
    Grilo, Carlos M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 400 - 406
  • [26] Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial
    Salehpour, A.
    Shidfar, F.
    Hosseinpanah, F.
    Vafa, M.
    Razaghi, M.
    Amiri, F.
    DIABETIC MEDICINE, 2013, 30 (12) : 1477 - 1481
  • [27] Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial
    Mirmiran, Parvin
    Fazeli, Mohammad Reza
    Asghari, Golaleh
    Shafiee, Abbas
    Azizi, Fereidoun
    BRITISH JOURNAL OF NUTRITION, 2010, 104 (03) : 402 - 406
  • [28] Use of metformin in obese adolescents with hyperinsulinemia: A 6-month, randomized, double-blind, placebo-controlled clinical trial
    Atabek, Mehmet Emre
    Pirgon, Ozgur
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2008, 21 (04) : 339 - 348
  • [29] Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
    Vinson, Joe A.
    Burnham, Bryan R.
    Nagendran, Mysore V.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 21 - 27
  • [30] Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial
    Zibaeenezhad, M. J.
    Farhadi, P.
    Attar, A.
    Mosleh, A.
    Amirmoezi, F.
    Azimi, A.
    NUTRITION & DIABETES, 2017, 7 : e259 - e259